Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in β-islet cell hyperplasia

Rane, Sushil G., Dubus, Pierre, Mettus, Richard V., Galbreath, Elizabeth J., Boden, Guenther, Reddy, E. Premkumar, Barbacid, Mariano·1999·Nature Genetics
DOI 10.1038/8751

Cited by (702)

Items 501–600 of 702

  1. Long-term treatment with EXf, a peptide analog of Exendin-4, improves β-cell function and survival in diabetic KKAy mice
    Guojiang Hou, Cai-na Li, Shuainan Liu, Yi Huan, Quan Liu, Sujuan Sun, Linyi Li, Shao-cong Hou, Zhufang Shen · 2013 · Peptides
  2. Modeling K-Ras-driven lung adenocarcinoma in mice: preclinical validation of therapeutic targets
    Matthias Drosten, Mariano Barbacid · 2015 · Journal of Molecular Medicine
  3. Hypothalamic CDK4 regulates thermogenesis by modulating sympathetic innervation of adipose tissues
    Judit Castillo‐Armengol, Valentin Barquissau, Sarah Geller, Honglei Ji, Ilenia Severi, Wiebe Venema, Eric Aria Fernandez, Catherine Moret, Katharina Huber, Lucía Carolina Leal-Esteban et al. · 2020 · EMBO Reports
  4. CDK4 IVS4‐nt40G→A and T2D‐associated obesity in Italians
    Ramachandran Meenakshisundaram, Claudia Gragnoli · 2009 · Journal of Cellular Physiology
  5. Ablation of epidermal RXRα in cooperation with activated CDK4 and oncogenic NRAS generates spontaneous and acute neonatal UVB induced malignant metastatic melanomas
    Sharmeen Chagani, Rong Wang, Evan L. Carpenter, Christiane V. Löhr, Gitali Ganguli‐Indra, Arup K. Indra · 2017 · BMC Cancer
  6. Potential biomarkers of resistance to CDK4/6 inhibitors: a narrative review of preclinical and clinical studies
    Weiyi Huang, Hongxia Wang · 2021 · Translational Breast Cancer Research
  7. Control of Ovarian Function
    Julia Andrea Elvin, Martin Matthew Matzuk · 2001 · Humana Press eBooks
  8. Inosine-5′-Monophosphate Dehydrogenase Is Required for Mitogenic Competence of Transformed Pancreatic β Cells**This work was supported in part by NIH Grant DK-37312.
    Stewart A. Metz, Scott Holland, Lisa Johnson, Erik Espling, Mary E. Rabaglia, Venkatesh Babu G. Segu, J. Scott Brockenbrough, Phuong Oanh T. Tran · 2001 · Endocrinology
  9. Overexpression of Pre-Pro-Cholecystokinin Stimulates β-Cell Proliferation in Mouse and Human Islets with Retention of Islet Function
    Jeremy A. Lavine, Philipp W. Raess, Dawn Belt Davis, Mary E. Rabaglia, Brent K. Presley, Mark P. Keller, Margery C. Beinfeld, Alan S. Kopin, Christopher B. Newgard, Alan Attie · 2008 · Molecular Endocrinology · Retracted
  10. Mutant mouse models and their contribution to our knowledge of corpus luteum development, function and regression
    Luiz E. Henkes, John S. Davis, Bo R. Rueda · 2003 · Reproductive Biology and Endocrinology
  11. A mutant allele of BARA/LIN-9 rescues the cdk4−/− phenotype by releasing the repression on E2F-regulated genes
    Raudel Sandoval, Jiaping Xue, Xinyong Tian, Kelly Barrett, Mark A. Pilkinton, David S. Ucker, Pradip Raychaudhuri, Rhonda Denise Kineman, Raul Miguel Luque, Gleb E. Baida et al. · 2006 · Experimental Cell Research
  12. Association of variants in CDKN2A/2B and CDKAL1 genes with gestational insulin sensitivity and disposition in pregnant Han Chinese women
    Jie Mei, Shunyao Liao, Yunqiang Liu, Yuan-De Tan, Hailian Wang, Yaming Liang, Xianjue Dong, Wenzhong Song, Lu Gan, Shaoping Deng · 2014 · Journal of Diabetes Investigation
  13. Ku70 Functions in Addition to Nonhomologous End Joining in Pancreatic β-Cells
    Omid Tavana, Nahum Puebla‐Osorio, Jiseong Kim, Mei Sang, Stella Jang, Chengming Zhu · 2013 · Diabetes
  14. Analysis of the interaction effect of 48 SNPs and obesity on type 2 diabetes in Chinese Hans
    Jia Liu, Lu Wang, Yun Qian, Qian Shen, Hai Chen, Hongxia Ma, Juncheng Dai, Chong Shen, Guangfu Jin, Zhibin Hu et al. · 2020 · BMJ Open Diabetes Research & Care
  15. Determinants of pancreatic β‐cell regeneration
    Abed Khalaileh, Tsufit Gonen‐Gross, Judith Magenheim, Tomer Nir, S. Porat, Seth J. Salpeter, Miri Stolovich-Rain, Avital Swisa, N. Weinberg, Yuval Dor · 2008 · Diabetes Obesity and Metabolism
  16. T Cell Proliferation and Homeostasis: An Emerging Role for the Cell Cycle Inhibitor Geminin
    Dimitris Karamitros, Panoraia Kotantaki, Zoi Lygerou, Dimitris Kioussis, Stavros L. Taraviras · 2011 · Critical Reviews in Immunology
  17. Functional annotation of mouse mutations in embryonic stem cells by use of expression profiling
    Derek J. Symula, Yiwen Zhu, John C. Schimenti, Edward M. Rubin · 2004 · Mammalian Genome
  18. Eukaryotic initiation factor 4B is a multi-functional RNA binding protein that regulates histone mRNAs
    Ana Quintas, Robert F. Harvey, Emilie Horvilleur, Gavin D. Garland, Tobias Schmidt, Lajos Kalmár, Veronica Dezi, Alberto Marini, Alexander M Fulton, Tuija A. A. Pöyry et al. · 2024 · Nucleic Acids Research
  19. The Impact of Genetic Variants for Different Physiological Characterization of Type 2 Diabetes Loci on Gestational Insulin Signaling in Nondiabetic Pregnant Chinese Women
    Shunyao Liao, Yunqiang Liu, Xiaojuan Chen, Yuan-De Tan, Jie Mei, Wenzhong Song, Lu Gan, Hailian Wang, Shi Yin, Xianjue Dong et al. · 2015 · Reproductive Sciences
  20. Association of CDKN2A/B gene polymorphisms (rs10811661 and rs2383208) with type 2 diabetes mellitus in a sample of Iraqi population
    Hussein K. Fadheel, Ahmed Naseer Kaftan, Farah H. Naser, Majid Kadhum Hussain, Abdul Hussein A. Algenabi, Hamza J. Mohammad, Thekra Abid Jaber Al-Kashwan · 2022 · Egyptian Journal of Medical Human Genetics
  21. Incretin hormones and beta-cell mass expansion: what we know and what is missing?
    Federica Tortosa, Francesco Dotta · 2013 · Archives of Physiology and Biochemistry
  22. Rapamycin Inhibits Growth Factor-Induced Cell Cycle Regulation in Pancreatic β Cells
    Amy Aronovitz, Jami L. Josefson, Amanda Dee Fisher, Marsha V. Newman, Elizabeth Hughes, Fei Chen, David S. Moons, Hiroaki Kiyokawa, William L. Lowe · 2008 · Journal of Investigative Medicine
  23. Evaluation of genetic melanoma vaccines in cdk4-mutant mice provides evidence for immunological tolerance against authochthonous melanomas in the skin
    Julia Steitz, Stefanie Büchs, Damiá Tormo, Aleix Ferrer, Joerg Wenzel, Christoph Huber, Thomas Wölfel, Mariano Barbacid, Marcos Malumbres, Thomas Tüting · 2005 · International Journal of Cancer
  24. A new, unexpected action of olomoucine, a CDK inhibitor, on normal human cells: Up‐regulation of CLIMP‐63, a cytoskeleton‐linking membrane protein
    Józefa Węsierska‐Gądek, Marieta Gueorguieva, Matthias P. Kramer, Carmen Ranftler, Bettina Sarg, Herbert H. Lindner · 2007 · Journal of Cellular Biochemistry
  25. New tricks for old dogs: unexpected roles for cell cycle regulators revealed using animal models
    Patrick Orson Humbert, Anthony M. Brumby, Leonie M. Quinn, Helena E. Richardson · 2004 · Current Opinion in Cell Biology
  26. Association of FTO, KCNJ11, SLC30A8, and CDKN2B polymorphisms with type 2 diabetes mellitus
    Alexey G. Nikitin, Viktor A. Potapov, А. Н. Бровкин, Е Ю Лаврикова, Д. С. Ходырев, Минара Шамхаловна Шамхалова, Сметанина Светлана Андреевна, Л. А. Суплотова, Marina Vladimirovna Shestakova, Valery Vyacheslavovich Nosikov et al. · 2015 · Molecular Biology
  27. Recombinant protein CCN5/WISP2 promotes islet cell proliferation and survival in vitro
    Nancy Kaddour, Di Zhang, Zu‐Hua Gao, Jun‐Li Liu · 2019 · Growth Factors
  28. Whole exome sequencing reveals novel candidate gene variants for MODY
    Özlem Yalçın Çapan, Neslihan Aydın, Temel M Yilmaz, Ergül Berber · 2020 · Clinica Chimica Acta
  29. Polycomb Repressive Complexes: Shaping Pancreatic Beta-Cell Destiny in Development and Metabolic Disease
    Sneha S. Varghese, Sangeeta Dhawan · 2022 · Frontiers in Cell and Developmental Biology
  30. Cell Cycle
    Elisa Ventura, Antonio Giordano · 2019 · Elsevier eBooks
  31. Cyclin-Dependent Kinase 4 Hyperactivity Promotes Autoreactivity in the Immune System but Protects Pancreatic β Cell Mass from Autoimmune Destruction in the Nonobese Diabetic Mouse Model
    Núria Marzo, Sagrario Ortega, Thomas Stratmann, Ainhoa García, Martín Ríos, América Giménez, Ramón Gomis, Conchi Mora · 2008 · The Journal of Immunology
  32. Haploinsufficiency of Insm1 Impairs Postnatal Baseline β-Cell Mass
    Weihua Tao, Yao Zhang, Lijuan Ma, Chujun Deng, Hualin Duan, Xuehua Liang, Rui Liao, Shaoqiang Lin, Tao Nie, Wanqun Chen et al. · 2018 · Diabetes
  33. Diabetes Mellitus: An Opportunity for Therapy with Stem Cells?
    Valeria Sordi, Federico Bertuzzi, Lorenzo Piemonti · 2008 · Regenerative Medicine
  34. Studies of variations of the cyclin-dependent kinase inhibitor 1C and the cyclin-dependent kinase 4 genes in relation to type 2 diabetes mellitus and related quantitative traits
    Eva-Maria Damsgaard Nielsen, Lars Hansen, Trine Stissing, Keiko Yanagisawa, Knut Borch‐Johnsen, Pernille Poulsen, Allan Arthur Vaag, Torben F. Hansen, Oluf Borbye Pedersen · 2005 · Journal of Molecular Medicine
  35. The CDKN1B-RB1-E2F1 pathway protects mouse spermatogonial stem cells from genomic damage
    Takashi Sonam Tashi Tanaka, Mito Kanatsu‐Shinohara, Takashi Shinohara · 2015 · Journal of Reproduction and Development
  36. The D-Type Cyclins: A Historical Perspective
    Charles J. Sherr, Piotr Siciński · 2017 · Current cancer research
  37. TRPM7 is a crucial regulator of pancreatic endocrine development and high-fat-diet-induced β-cell proliferation
    Molly K. Altman, Charles M. Schaub, Prasanna K. Dadi, Matthew T. Dickerson, Karolina E. Zaborska, Arya Y. Nakhe, Sarah M. Graff, Thomas J. Galletta, Gautami Amarnath, Ariel S. Thorson et al. · 2021 · Development
  38. Quiescence regulation by normal haematopoietic stem cells and leukaemia stem cells
    Kristbjorn O. Gudmundsson, Yang Du · 2022 · FEBS Journal
  39. CDK4 IVS4-nt40 AA genotype and obesity-associated tumors/cancer in Italians – a case-control study
    Ramachandran Meenakshisundaram, Claudia Gragnoli · 2009 · Journal of Experimental & Clinical Cancer Research
  40. Redox homeostasis and cell cycle activation mediate beta-cell mass expansion in aged, diabetes-prone mice under metabolic stress conditions: Role of thioredoxin-interacting protein (TXNIP)
    Richard Kehm, Markus Jähnert, Stefanie Deubel, Tanina Flore, Jeannette König, Tobias Jung, Mandy Stadion, Wenke Jonas, Annette Schürmann, Tilman Grune et al. · 2020 · Redox Biology
  41. Targeted Overexpression of CKI-Insensitive Cyclin-Dependent Kinase 4 Increases Functional β -Cell Number Through Enhanced Self-Replication in Zebrafish
    Mingyu Li, Lisette A. Maddison, Zachary David Crees, Wenbiao Chen · 2013 · Zebrafish
  42. Molecular and cellular key players in human islet transplantation
    Martin Hermann, R. Margreiter, Paul Hengster · 2007 · Journal of Cellular and Molecular Medicine
  43. Suppression of hepatitis C virus replication by cyclin-dependent kinase inhibitors
    Tsubasa Munakata, Makoto Inada, Yuko Tokunaga, Takaji Wakita, Michinori Kohara, Akio Nomoto · 2014 · Antiviral Research
  44. Allelic Variation on Chromosome 5 Controls β-Cell Mass Expansion during Hyperglycemia in Leptin Receptor-Deficient Diabetes Mice
    Na Luo, Shun-Mei Liu, Hong Shu Liu, Qiong Li, Qun Xu, Xi Sun, Brandi Davis, Jing Li, Streamson C. Chua · 2006 · Endocrinology
  45. Resistance Mechanisms to Cyclin-Dependent Kinase Inhibitors
    Wiedemeyer, Wolf Ruprecht · 2018 · Resistance to Targeted Anti-Cancer Therapeutics
  46. Prediction of allosteric druggable pockets of cyclin-dependent kinases
    Shangbo Ning, Huiwen Wang, Chen Zeng, Yunjie Zhao · 2022 · Briefings in Bioinformatics
  47. β-Cell–Specific E2f1 Deficiency Impairs Glucose Homeostasis, β-Cell Identity, and Insulin Secretion
    Frédérik Oger, Cyril Bourouh, Marika Elsa Friano, Émilie Courty, Laure Rolland, Xavier Gromada, Maeva Moreno, Charlène Carney, Nabil Rabhi, Emmanuelle Durand et al. · 2023 · Diabetes
  48. Present Accomplishments and Future Prospects of Cell-Based Therapies for Type 1 Diabetes Mellitus
    Preeti Chhabra, Daniel L Clark, Daniel J., L. Bost Kenneth · 2011 · InTech eBooks
  49. The N-terminal Peptide of the Kaposi's Sarcoma-associated Herpesvirus (KSHV)-cyclin Determines Substrate Specificity
    Philipp Kaldis · 2005 · Journal of Biological Chemistry
  50. The CDK4/6 Inhibitor PD0332991 Reverses Epithelial Dysplasia Associated with Abnormal Activation of the Cyclin-CDK-Rb Pathway
    M. Carla Cabrera, Edgar S. Díaz‐Cruz, Bhaskar Kallakury, Michael Jon Pishvaian, Clinton J. Grubbs, Donald D. Muccio, Priscilla A. Furth · 2012 · Cancer Prevention Research
  51. Mice lacking cyclin‐dependent kinase inhibitor p19Ink4d show strain‐specific effects on male reproduction
    Gregory M. Buchold, Patricia L. Magyar, Deborah A. O’Brien · 2007 · Molecular Reproduction and Development
  52. Evaluation of Pancreatic and Extra Pancreatic Effects of Branched Amino Acids
    Moath Alqaraleh, Violet N. Kasabri, Sundus Alalawi, Nihad Al-Othman · 2019 · Romanian Journal of Diabetes Nutrition and Metabolic Diseases
  53. Harnessing beta-cell replication: advancing molecular insights to regenerative therapies in diabetes
    Rupangi C. Vasavada, Sangeeta Dhawan · 2025 · Frontiers in Endocrinology
  54. Pancreatic cells and their progenitors.
    S. Salpeter, Y. Dor · 2006 · Methods in Enzymology
  55. Regulation of the Cell Cycle and Interventional Developmental Therapeutics
    Stacey M. Ivanchuk, James T. Rutka · 2006 · Elsevier eBooks
  56. Immunohistochemical Investigation of F344/N Rat Islet Cell Tumors from National Toxicology Program Studies
    Christopher S. Koivisto, Gordon P. Flake, Holly Kolenda‐Roberts, Tiwanda Masinde, Grace E. Kissling, Robert C. Sills, Mark James Hoenerhoff · 2012 · Toxicologic Pathology
  57. Dnmt1 activity is dispensable in δ-cells but is essential for α-cell homeostasis
    Nicolas Damond, Fabrizio Thorel, Seung K. Kim, Pedro Luis Herrera · 2017 · The International Journal of Biochemistry & Cell Biology
  58. About three‐fourths of mouse proteins unexpectedly appear at a low position of SDS‐PAGE, often as additional isoforms, questioning whether all protein isoforms have been eliminated in gene‐knockout cells or organisms
    Jiayuan Qu, Ju Zhang, Lucas Zellmer, Yan He, Siqi Liu, Chenguang Wang, Chengfu Yuan, Ningzhi Xu, Hai Huang, Dezhong Joshua Liao · 2020 · Protein Science
  59. Activated Hgf-Met Signaling Cooperates with Oncogenic BRAF to Drive Primary Cutaneous Melanomas and Angiotropic Lung Metastases in Mice
    Andreas Dominik Braun, Miriam Mengoni, Susanne Bonifatius, Thomas Tüting, Evelyn Gaffal · 2020 · Journal of Investigative Dermatology
  60. Coming Full Circle: Cyclin-Dependent Kinases as Anti-cancer Drug Targets
    Robert P. Fisher · 2009 · Sub-cellular biochemistry/Subcellular biochemistry
  61. Modeling Cell Cycle Control and Cancer with pRB Tumor Suppressor
    Lili Yamasaki · 2006 · Springer eBooks
  62. Emerging Roles of Cell Cycle Regulators in Adipocyte Metabolism
    Carine Chavey A, Sylviane Lagarrigue, Jean‐Sébastien Annicotte, Lluis Fajas A · 2012 · Springer eBooks
  63. Germline Modification Strategies
    Silvia Grisendi, Pier Paolo Pandolfi · 2004
  64. Palbociclib and dsRNA sensor co-operate to enhance anti-cancer effects through ER stress and modulation of immune evasion
    V. Roulstone, J. Kyula-Currie, James Wright, E. Patin, Isaac Dean, Lu Yu, Aida Barreiro-Alonso, Miriam Melake, J. Choudhary, R. Elliott et al. · 2025 · Nature Communications
  65. The Therapeutic Potential of CDK4/6 Inhibitors, Novel Cancer Drugs, in Kidney Diseases
    Xuan-Bing Liang, Zhi-Cheng Dai, Rong Zou, Ji‐Xin Tang, Cuiwei Yao · 2023 · International Journal of Molecular Sciences
  66. CDK6: an attractive therapeutic target for T-ALL/LBL
    Wei Li, Jamie Katy Hu, Miaofen G. Hu · 2023 · Expert Opinion on Therapeutic Targets
  67. CDK4: Linking cell size to cell cycle control
    Yiqin Ma, Bruce A. Edgar · 2021 · Developmental Cell
  68. Deficiency of M-LP/Mpv17L leads to development of β-cell hyperplasia and improved glucose tolerance via activation of the Wnt and TGF-β pathways
    Reiko Iida, Misuzu Ueki, Toshihiro Yasuda · 2021 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  69. ANRIL: A Long Noncoding RNA in Age-related Diseases
    Rui Wang, Qi X. Yuan, Yuan Wen, Yifan Zhang, Yaqi Hu, Shuwen Wang, Chengfu Yuan · 2024 · Mini-Reviews in Medicinal Chemistry
  70. Network pharmacological mechanism and molecular experimental validation of artemisinin in the treatment of lung adenocarcinoma
    Zhimin Lu, Jialu Jiang, Xuming Yao, Guoxin Hou · 2025 · Toxicology and Applied Pharmacology
  71. Le double jeu des régulateurs du cycle cellulaire
    Sylviane Lagarrigue, Émilie Blanchet, Jean‐Sébastien Annicotte, Lluis Fajas A · 2011 · médecine/sciences
  72. The Contribution of Reg Family Proteins to Cell Growth and Survival in Pancreatic Islets
    Qing Li, Xiaoquan Xiong, Jun‐Li Liu · 2014 · Springer eBooks
  73. Functional Studies of Menin through Genetic Manipulation of the Men1 Homolog in Mice
    Dheepa Balasubramanian, Peter C. Scacheri · 2009 · Advances in experimental medicine and biology
  74. CDK4 IVS4-nt40G→A SNP and type 2 diabetes in Italians
    Ramachandran Meenakshisundaram, Nunzia Piumelli, Laura Pierpaoli, Claudia Gragnoli · 2009 · Diabetes Research and Clinical Practice
  75. Two Faces of Evil: Cancer and Neurodegeneration
    Curran, Thomas, Yves Christen · 2010 · Research and perspectives in Alzheimer's disease
  76. CDK4 Phosphorylates AMPKα2 to Inhibit Its Activity and Repress Fatty Acid Oxidation
    Isabel C. López‐Mejía, Sylviane Lagarrigue, Albert Giralt, Laia Martínez-Carreres, Javier Martín, Sagrario Ortega, Nadège Zanou, Pierre‐Damien Denechaud, Judit Castillo‐Armengol, Carine Chavey A et al. · 2024 · Molecular Cell
  77. Real-World Data Analysis of CDK4/6 Inhibitor Therapy—A Patient-Centric Single Center Study
    Isabell Ge, Kai Berner, Marlene Mathis, Catherine Hensgen, Sebastian Mayer, Thalia Erbes, Ingolf Juhasz‐Böss, Jasmin Asberger · 2024 · Cancers
  78. CDK6-Dependent, CDK4-Independent Synovial Hyperplasia in Arthritic Mice and Tumor Necrosis Factor-α-Induced Proliferation of Synovial Fibroblasts
    Rie Komatsu, Ryoji Fujii, Toru Ogasawara, Yuki Suzuki‐Takahashi, Sandy Chen, Yodo Sugishita, Hisateru Niki, Kazuo Yudoh · 2025 · International Journal of Molecular Sciences
  79. Evasion of G1 Checkpoints in Cancer
    Krijn Kristian Dijkstra, Cristophe Blanchetot, Johannes Boonstra · 2009 · Humana Press eBooks
  80. Solexa Profiling Identifies Differentially Expressed MiRNAs Between Sexually Immature and Mature Equine Testis
    Liangjun He, Shiwei Wang, Haifeng Deng, Hong Dong, Jingbo Chen · 2018 · Brazilian Archives of Biology and Technology
  81. The Altered Metabolic Molecular Signatures Contribute to the RAD001 Resistance in Gastric Neuroendocrine Tumor
    Jie Pan, Qi Bao, Georg A. Enders · 2020 · Frontiers in Oncology
  82. DDX18 Facilitates the Tumorigenesis of Lung Adenocarcinoma by Promoting Cell Cycle Progression through the Upregulation of CDK4
    Bingbing Feng, Xinying Wang, Ding Qiu, Haiyang Sun, Jianping Deng, Ying Ching Tan, Kaile Ji, Shaoting Xu, Shuishen Zhang, Ce Tang · 2024 · International Journal of Molecular Sciences
  83. Cell cycle control factors and skeletal development
    Toru Ogasawara · 2013 · Japanese Dental Science Review
  84. Mammalian Development and Cancer: A Brief History of Mice Lacking D-Type Cyclins or CDK4/CDK6
    Ilona Kalaszczyńska, Maria A. Ciemerych · 2017 · Current cancer research
  85. Genetic mouse models to investigate cell cycle regulation
    Weimin Li, Shuhei Kotoshiba, Philipp Kaldis · 2009 · Transgenic Research
  86. Obstacles to Translating Genotype-Phenotype Correlates in Metabolic Disease
    Anu Rani Sharma, Adrian V Vella · 2016 · Physiology
  87. Roscovitine treatment caused impairment of fertilizing ability in mice
    Xiang L. Yin, Qi Yan, Ming Ren, Shuyu Wang, Hongquan Jiang, Honglin Feng, Shangjin Cui · 2015 · Toxicology Letters
  88. Cell-cycle targeted cancer therapy: clinical advances, biological gaps, and the emergence of selective CDK4 inhibitors
    Ava Safaroghli‐Azar, Laychiluh Bantie Mekonnen, Jimma Likisa Lenjisa, Robert W. Milne, Shudong Wang · 2026 · Journal of Hematology & Oncology
  89. Noncanonical CDK4 signaling rescues diabetes in a mouse model by promoting β cell differentiation
    Rachel E. Stamateris, Huguet V. Landa-Galván, Rohit B. Sharma, Christine Darko, David Redmond, Sushil G. Rane, Laura C. Alonso · 2023 · Journal of Clinical Investigation
  90. Safeguarding genomic integrity in beta-cells: implications for beta-cell differentiation, growth, and dysfunction
    Sneha S. Varghese, Alessandro Giovanni Hernandez-De La Peña, Sangeeta Dhawan · 2024 · Biochemical Society Transactions
  91. The Application of Gene Ablation and Related Technologies to the Study of Ovarian Function
    Kathleen H. Burns, Martin Matthew Matzuk · 2004 · Elsevier eBooks
  92. Cyclin-Dependent Kinases and Their Regulators as Potential Targets for Anticancer Therapeutics
    Marcos Malumbres · 2008 · Humana Press eBooks
  93. Regulation of Cell Cycle During Liver Regeneration
    Yulia Alexandrowna Nevzorova, Christian Trautwein · 2015 · Elsevier eBooks
  94. « Cycler » sans cycline D
    Valérie Lobjois · 2005 · Érudit (Université de Montréal)
  95. CDK4, cible thérapeutique des adénocarcinomes pulmonaires porteurs d’une mutation de l’oncogèneKRAS
    Pierre R. Dubus · 2010 · médecine/sciences
  96. Reduced expression of the LRP16 gene in mouse insulinoma (MIN6) cells exerts multiple effects on insulin content, proliferation and apoptosis
    Xiaojin Li, Bing Xue, Xuan Wang, Lianqing Sun, Tingting Zhang, Ling Qu, Xiaoman Zou, Yiming Mu · 2012 · Journal of Huazhong University of Science and Technology [Medical Sciences]
  97. The Role of PTEN in β-Cell Growth
    Bangyan L. Stiles · 2010 · The Open Endocrinology Journal
  98. Cell Cycle Plasticity and Heterogeneity: An Underappreciated Feature of Cancer and Treatment Response
    Erik S. Knudsen, Thomas N. O’Connor, Agnieszka Katarzyna Witkiewicz · 2025 · Cancer Heterogeneity and Plasticity
  99. Dual-Input Regulation of β-Cell Proliferation by ATF6α and Glucose via E2F1
    Huguet V. Landa-Galván, THALIA A. CASTRO, Jahi J. Noel, Gabriel Avila Llamas, Rohit B. Sharma, Laura C. Alonso · 2025 · Diabetes
  100. Frontiers in Cell-Cycle-Targeting Therapies: Addressing the Heterogeneity of the Cancer Cell Cycle
    Ishaar P. Ganesan, Hiroaki Kiyokawa · 2026 · Cancers